4//SEC Filing
Inbar Galia 4
Accession 0001209191-22-017051
CIK 0000818686other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:09 PM ET
Size
10.0 KB
Accession
0001209191-22-017051
Insider Transaction Report
Form 4
Inbar Galia
See "Remarks"
Transactions
- Exercise/Conversion
Ordinary Shares
2022-03-05+5,710→ 15,366 total - Exercise/Conversion
Restricted Share Units
2022-03-05−5,710→ 17,132 total→ Ordinary Shares (5,710 underlying) - Award
Restricted Share Units
2022-03-04+80,428→ 80,428 total→ Ordinary Shares (80,428 underlying)
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on March 4, 2022, with 20,107 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026.
- [F4]Restricted share units were granted on March 5, 2021, with 5,710 vesting on each of March 5, 2022, March 5, 2023 and March 5, 2024 and 5,712 vesting on March 5, 2025.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001878086
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:09 PM ET
- Size
- 10.0 KB